Search research articles
Contact Us
Filters
Showing results (111-120 of 140) with videos related to
Page
of 14
Sort By:
Spine
|
March 5, 2024
Predictors for Failure to Respond to Erector Spinae Plane Block Following Minimally Invasive Transforaminal Lumbar Interbody Fusion
Eric Mai, Joshua Zhang, Amy Z Lu, et al.
JAMA
|
September 11, 2019
Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial
S R Rathinam, John A Gonzales, Radhika Thundikandy, et al.
Ophthalmology Science
|
March 12, 2026
Influence of Social Determinants of Health on Presenting Visual Acuity in Retinal Vein Occlusions
Sidra Zafar, Bita Momenaei, Roselind Ni, et al.
Clinical and Translational Radiation Oncology
|
June 17, 2021
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis
Amit Roy, Randall J Brenneman, Jacob Hogan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 15, 2026
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial
Ana Baramidze, Tamta Makharadze, Miranda Gogishvili, et al.
The Journal of Urology
|
June 13, 2019
Ten-Year Oncologic Outcomes Following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
Ahmed A Hussein, Ahmed S Elsayed, Naif A Aldhaam, et al.
Urologic Oncology
|
March 1, 2024
The role of neoadjuvant chemotherapy for patients with variant histology muscle invasive bladder cancer undergoing robotic cystectomy: Data from the International Robotic Cystectomy Consortium
Ian Cooke, Nassib Abou Heidar, Abdul Wasay Mahmood, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 21, 2025
Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1
Saadettin Kilickap, Ana Baramidze, Ahmet Sezer, et al.
Plos One
|
November 3, 2012
Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate
Stella Aslibekyan, Mark O Goodarzi, Alexis C Frazier-Wood, et al.
The Journal of Urology
|
October 11, 2019
Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC
Naif A Aldhaam, Ahmed S Elsayed, Zhe Jing, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 140) with videos related to
Sort By:
Page
of 14
Spine
|
March 5, 2024
Predictors for Failure to Respond to Erector Spinae Plane Block Following Minimally Invasive Transforaminal Lumbar Interbody Fusion
Eric Mai, Joshua Zhang, Amy Z Lu, et al.
JAMA
|
September 11, 2019
Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial
S R Rathinam, John A Gonzales, Radhika Thundikandy, et al.
Ophthalmology Science
|
March 12, 2026
Influence of Social Determinants of Health on Presenting Visual Acuity in Retinal Vein Occlusions
Sidra Zafar, Bita Momenaei, Roselind Ni, et al.
Clinical and Translational Radiation Oncology
|
June 17, 2021
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis
Amit Roy, Randall J Brenneman, Jacob Hogan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 15, 2026
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial
Ana Baramidze, Tamta Makharadze, Miranda Gogishvili, et al.
The Journal of Urology
|
June 13, 2019
Ten-Year Oncologic Outcomes Following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
Ahmed A Hussein, Ahmed S Elsayed, Naif A Aldhaam, et al.
Urologic Oncology
|
March 1, 2024
The role of neoadjuvant chemotherapy for patients with variant histology muscle invasive bladder cancer undergoing robotic cystectomy: Data from the International Robotic Cystectomy Consortium
Ian Cooke, Nassib Abou Heidar, Abdul Wasay Mahmood, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 21, 2025
Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1
Saadettin Kilickap, Ana Baramidze, Ahmet Sezer, et al.
Plos One
|
November 3, 2012
Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate
Stella Aslibekyan, Mark O Goodarzi, Alexis C Frazier-Wood, et al.
The Journal of Urology
|
October 11, 2019
Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC
Naif A Aldhaam, Ahmed S Elsayed, Zhe Jing, et al.
Page
of 14